JP Morgan Chase’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$173K Buy
21,541
+187
+0.9% +$1.94K ﹤0.01% 5544
2025
Q4
$264K Sell
21,354
-1,074
-5% -$11.5K ﹤0.01% 5387
2025
Q3
$198K Sell
22,428
-3,175
-12% -$24.7K ﹤0.01% 5523
2025
Q2
$163K Sell
25,603
-188,144
-88% -$1.08M ﹤0.01% 5347
2025
Q1
$1.04M Buy
213,747
+213,313
+49,150% +$1.77M ﹤0.01% 4329
2024
Q4
$4.15K Sell
434
-209
-33% -$1.92K ﹤0.01% 6543
2024
Q3
$5.37K Sell
643
-648,859
-100% -$5.9M ﹤0.01% 6470
2024
Q2
$4.43M Buy
649,502
+375,962
+137% +$1.62M ﹤0.01% 3125
2024
Q1
$692K Buy
273,540
+222,583
+437% +$502K ﹤0.01% 4592
2023
Q4
$122K Sell
50,957
-242
-0.5% -$569 ﹤0.01% 5644
2023
Q3
$174K Buy
51,199
+7,859
+18% +$43.6K ﹤0.01% 5150
2023
Q2
$319K Sell
43,340
-26,721
-38% -$248K ﹤0.01% 4779
2023
Q1
$726K Sell
70,061
-174,182
-71% -$2.11M ﹤0.01% 4259
2022
Q4
$2.88M Buy
244,243
+181,213
+288% +$2.8M ﹤0.01% 3275
2022
Q3
$1.32M Sell
63,030
-104,184
-62% -$2.9M ﹤0.01% 3794
2022
Q2
$5.19M Buy
167,214
+8,421
+5% +$288K ﹤0.01% 2765
2022
Q1
$6.52M Buy
158,793
+110,909
+232% +$4.89M ﹤0.01% 2775
2021
Q4
$2.08M Sell
47,884
-47,003
-50% -$2.13M ﹤0.01% 3833
2021
Q3
$4.75M Sell
94,887
-4,657
-5% -$282K ﹤0.01% 3070
2021
Q2
$6.27M Sell
99,544
-3,537
-3% -$227K ﹤0.01% 2855
2021
Q1
$9.58M Sell
103,081
-78,735
-43% -$8.06M ﹤0.01% 2400
2020
Q4
$16.3M Sell
181,816
-9,278
-5% -$852K ﹤0.01% 1796
2020
Q3
$19.9M Buy
191,094
+142,592
+294% +$15.4M ﹤0.01% 1494
2020
Q2
$3.83M Buy
48,502
+25,745
+113% +$1.92M ﹤0.01% 2656
2020
Q1
$1.32M Sell
22,757
-586
-3% -$33.8K ﹤0.01% 3238
2019
Q4
$1.26M Buy
23,343
+255
+1% +$13.8K ﹤0.01% 3687
2019
Q3
$1.21M Sell
23,088
-250
-1% -$11.6K ﹤0.01% 3723
2019
Q2
$1.12M Buy
23,338
+1,272
+6% +$61K ﹤0.01% 3789
2019
Q1
$1.11M Sell
22,066
-21,923
-50% -$1.29M ﹤0.01% 3737
2018
Q4
$2.61M Buy
43,989
+17,210
+64% +$1.11M ﹤0.01% 3096
2018
Q3
$1.76M Buy
26,779
+4,980
+23% +$291K ﹤0.01% 3545
2018
Q2
$1.1M Sell
21,799
-35,146
-62% -$1.83M ﹤0.01% 3773
2018
Q1
$3M Sell
56,945
-22,210
-28% -$1.11M ﹤0.01% 2991
2017
Q4
$3.68M Buy
79,155
+65,667
+487% +$2.76M ﹤0.01% 2920
2017
Q3
$537K Sell
13,488
-187
-1% -$6.77K ﹤0.01% 3802
2017
Q2
$463K Buy
13,675
+442
+3% +$13.6K ﹤0.01% 3761
2017
Q1
$384K Buy
13,233
+257
+2% +$7.82K ﹤0.01% 3824
2016
Q4
$426K Sell
12,976
-65,724
-84% -$1.97M ﹤0.01% 3851
2016
Q3
$2.48M Buy
78,700
+64,327
+448% +$1.87M ﹤0.01% 2673
2016
Q2
$404K Buy
14,373
+548
+4% +$21.5K ﹤0.01% 3517
2016
Q1
$503K Sell
13,825
-6,791
-33% -$240K ﹤0.01% 3343
2015
Q4
$824K Sell
20,616
-4,137
-17% -$144K ﹤0.01% 3194
2015
Q3
$705K Sell
24,753
-923
-4% -$30.4K ﹤0.01% 3287
2015
Q2
$846K Buy
25,676
+3,176
+14% +$98.5K ﹤0.01% 3357
2015
Q1
$647K Sell
22,500
-200
-0.9% -$5.74K ﹤0.01% 3429
2014
Q4
$618K Sell
22,700
-1,716
-7% -$40.9K ﹤0.01% 3585
2014
Q3
$520K Buy
24,416
+1,312
+6% +$30K ﹤0.01% 3649
2014
Q2
$520K Buy
23,104
+4,450
+24% +$104K ﹤0.01% 3101
2014
Q1
$472K Buy
+18,654
New +$471K ﹤0.01% 3148
2013
Q4
Sell
-53,620
Closed -$1.02M 4128
2013
Q3
$1.02M Buy
53,620
+11,397
+27% +$203K ﹤0.01% 3253
2013
Q2
$609K Buy
+42,223
New +$611K ﹤0.01% 3511

Other funds holding EBS